Related Experiment Video
Updated: Feb 11, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
22.2K
Where are we with haemolytic uremic syndrome?
Teresa Cavero1, Marina Alonso2
1Servicio de Nefrología, Hospital 12 de Octubre, Madrid, España.
Medicina Clinica
|April 28, 2018
Summary
Haemolytic uremic syndrome (HUS) involves anemia and kidney injury, often due to complement pathway issues in atypical forms. Complement inhibitors like eculizumab offer revolutionary treatment for this serious condition.
Area of Science:
- Nephrology
- Hematology
- Immunology
Background:
- Haemolytic uremic syndrome (HUS) is a condition marked by microangiopathic hemolytic anemia and acute kidney injury.
- HUS is primarily categorized into Shiga-toxin producing E. coli-HUS (STEC-HUS) and atypical HUS (aHUS).
- Endothelial cell damage is a central mechanism leading to thrombotic microangiopathy in HUS.
Purpose of the Study:
- To review the classification and underlying mechanisms of HUS, focusing on atypical forms.
- To highlight the role of the alternative complement pathway in aHUS.
- To discuss current therapeutic strategies and their impact on HUS prognosis.
Main Methods:
- Literature review of HUS classification, pathophysiology, and treatment.
- Analysis of the role of complement system hyperactivity in aHUS.
- Evaluation of complement inhibitors, such as eculizumab, in managing HUS.
Main Results:
- Atypical HUS encompasses primary, secondary, and metabolic disease-related forms.
- Hyperactivity of the alternative complement pathway is implicated in most aHUS cases.
- Eculizumab has transformed HUS treatment by targeting complement pathways, though relapses post-transplant remain a concern.
Conclusions:
- Understanding the complement system's role is crucial for managing aHUS.
- Complement inhibitors represent a significant advancement in HUS therapy.
- Despite treatment advances, HUS, particularly after kidney transplant, presents ongoing prognostic challenges.
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
689
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
689
01:30Acute Coronary Syndrome I: Introduction
1.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
01:17Irritable Bowel Syndrome I: Introduction
1.1K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.1K
01:27Restless Leg Syndrome and Night Terrors
583
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
583
01:26Acute Coronary Syndrome V: Nursing Management
355
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
355
01:26Nephrotic Syndrome II : Assessment and Medical Management
249
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
249